Antigenic profiling of a Chlamydia trachomatis gene-expression library

Journal of Infectious Diseases

Volumn 197, Issue 6, 2008, Pages 897-905

  Follmann, Frank ^a   Olsen, Anja Weinreich ^a   Jensen, Klaus Thorleif ^a,c   Hansen, Paul Robert ^b   Andersen, Peter ^a   Theisen, Michael ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; CT004 ANTIGEN; CT043 ANTIGEN; CT082 ANTIGEN; CT089 ANTIGEN; CT110 ANTIGEN; CT184 ANTIGEN; CT322 ANTIGEN; CT396 ANTIGEN; CT443 ANTIGEN; CT509 ANTIGEN; CT611 ANTIGEN; CT681 ANTIGEN; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; CELL MEMBRANE; CHLAMYDIA TRACHOMATIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE LIBRARY; HUMAN; HUMAN CELL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN TARGETING; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; B-LYMPHOCYTES; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GENE EXPRESSION; GENE LIBRARY; HUMANS; MALE; MIDDLE AGED; SUBCELLULAR FRACTIONS; T-LYMPHOCYTES;

EID: 40949100512     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/528378     Document Type: Article

References (50)

1. World Health Organization (WHO). Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. Geneva, Switzerland: WHO, 2001.
2. Golden MR, Schillinger JA, Markowitz L, St Louis ME. Duration of untreated genital infections with Chlamydia trachomatis: a review of the literature. Sex Transm Dis 2000; 27:329-37.
3. Dean D, Suchland RJ, Stamm WE. Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J Infect Dis 2000; 182:909-16.
4. Westrom L, Joesoef R, Reynolds G, Hagdu A, Thompson SE. Pelvic inflammatory disease and fertility: a cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992; 19:185-92.
5. Brunham RC, Kimani J, Bwayo J, et al. The epidemiology of Chlamydia trachomatis within a sexually transmitted diseases core group. J Infect Dis 1996; 173:950-6.
6. Pepin J, Plummer FA, Brunham RC, Piot P, Cameron DW, Ronald AR. The interaction of HIV infection and other sexually transmitted diseases: an opportunity for intervention. AIDS 1989; 3:3-9.
7. Anttila T, Saikku P, Koskela P, et al. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA 2001; 285:47-51.
8. Rank RG, Ramsey KH, Pack EA, Williams DM. Effect of gamma interferon on resolution of murine chlamydial genital infection. Infect Immun 1992; 60:4427-9.
9. Johansson M, Schon K, Ward M, Lycke N. Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response. Infect Immun 1997; 65:1032-44.
10. Yang X, HayGlass KT, Brunham RC. Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J Immunol 1996; 156:4338-44.
11. Cohen CR, Koochesfahani KM, Meier AS, et al. Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon-γ. J Infect Dis 2005; 192:591-9.
12. Su H, Parnell M, Caldwell HD. Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection. Vaccine 1995; 13:1023-32.
13. Moore T, Ananaba GA, Bolier J, et al. Fc receptor regulation of protective immunity against Chlamydia trachomatis. Immunology 2002; 105:213-21.
14. Morrison SG, Morrison RP. Resolution of secondary Chlamydia trachomatis genital tract infection in immune mice with depletion of both CD4+ and CD8+ T cells. Infect Immun 2001; 69:2643-9.
15. Moore T, Ekworomadu CO, Eko FO, et al. Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens. J Infect Dis 2003; 188:617-24.
16. Sharma J, Zhong Y, Dong F, Piper JM, Wang G, Zhong G. Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins. Infect Immun 2006; 74:1490-9.
17. Pizza M, Scarlato V, Masignani V, et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000; 287:1816-20.
18. Montigiani S, Falugi F, Scarselli M, et al. Genomic approach for analysis of surface proteins in Chlamydia pneumoniae. Infect Immun 2002; 70:368-79.
19. Graham SP, Honda Y, Pelle R, et al. A novel strategy for the identification of antigens that are recognised by bovine MHC class I restricted cytotoxic T cells in a protozoan infection using reverse vaccinology. Immunome Res 2007; 3:2.
20. Saren A, Pascolo S, Stevanovic S, et al. Identification of Chlamydia pneumoniae-derived mouse CD8 epitopes. Infect Immun 2002; 70:3336-43.
21. Belland RJ, Zhong G, Crane DD, et al. Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. Proc Natl Acad Sci USA 2003; 100:8478-83.
22. Stephens RS, Kalman S, Lammel C, et al. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 1998; 282:754-9.
23. Yu CS, Lin CJ, Hwang JK. Predicting subcellular localization of proteins for gram-negative bacteria by support vector machines based on n-peptide compositions. Protein Sci 2004; 13:1402-6.
24. Jensen KT, Petersen L, Falk S, et al. Novel overlapping coding sequences in Chlamydia trachomatis. FEMS Microbiol Lett 2006; 265:106-17.
25. Sauvé DM, Ho DT, Roberge M. Concentration of dilute protein for gel electrophoresis. Anal Biochem 1995; 226:382-3.
26. Olsen AW, Follmann F, Højrup P, et al. Identification of human T cell targets recognized during Chlamydia trachomatis genital infection. J Infect Dis 2007; 196:1546-52.
27. Theisen M, Vuust J, Gottschau A, Jepsen S, Hogh B. Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli. Clin Diagn Lab Immunol 1995; 2:30-4.
28. Theisen M, Soe S, Jessing SG, et al. Identification of a major B-cell epitope of the Plasmodium falciparum glutamate-rich protein (GLURP), targeted by human antibodies mediating parasite killing. Vaccine 2000; 19:204-12.
29. Olsen AW, Follmann F, Jensen K, et al. Identification of CT521 as a frequent target of Th1 cells in patients with urogenital Chlamydia trachomatis infection. J Infect Dis 2006; 194:1258-66.
30. Stephens RS. Chlamydial genomics and vaccine antigen discovery. J Infect Dis 2000; 181(Suppl 3):S521-3.
31. Stemke-Hale K, Kaltenboeck B, DeGraves FJ, et al. Screening the whole genome of a pathogen in vivo for individual protective antigens. Vaccine 2005; 23:3016-25.
32. Brunham RC, Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol 2005; 5:149-61.
33. Skipp P, Robinson J, O'Connor CD, Clarke IN. Shotgun proteomic analysis of Chlamydia trachomatis. Proteomics 2005; 5:1558-73.
34. Shaw AC, Gevaert K, Demol H, et al. Comparative proteome analysis of Chlamydia trachomatis serovar A, D and L2. Proteomics 2002; 2:164-86.
35. Sanchez-Campillo M, Bini L, Comanducci M, et al. Identification of immunoreactive proteins of Chlamydia trachomatis by Western blot analysis of a two-dimensional electrophoresis map with patient sera. Electrophoresis 1999; 20:2269-79.
36. Larsen B, Birkelund S, Mordhorst CH, Ejstrup L, Andersen LS, Christiansen G. The humoral immune response to Chlamydia trachomatis in patients with acute reactive arthritis. Br J Rheumatol 1994; 33:534-40.
37. Stephens RS, Wagar EA, Schoolnik GK. High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis. J Exp Med 1988; 167:817-31.
38. Zhong GM, Reid RE, Brunham RC. Mapping antigenic sites on the major outer membrane protein of Chlamydia trachomatis with synthetic peptides. Infect Immun 1990; 58:1450-5.
39. Marques MA, Chitale S, Brennan PJ, Pessolani MC. Mapping and identification of the major cell wall-associated components of Mycobacterium leprae. Infect Immun 1998; 66:2625-31.
40. Dallo SF, Kannan TR, Blaylock MW, Baseman JB. Elongation factor Tu and E1 beta subunit of pyruvate dehydrogenase complex act as fibronectin binding proteins in Mycoplasma pneumoniae. Mol Microbiol 2002; 46:1041-51.
41. Raulston JE, Davis CH, Schmiel DH, Morgan MW, Wyrick PB. Molecular characterization and outer membrane association of a Chlamydia trachomatis protein related to the hsp70 family of proteins. J Biol Chem 1993; 268:23139-47.
42. Arno JN, Xie C, Jones RB, Van Der Pol B. Identification of T cells that respond to serovar-specific regions of the Chlamydia trachomatis major outer membrane protein in persons with serovar E infection. J Infect Dis 1998; 178:1713-8.
43. Gaston JS, Deane KH, Jecock RM, Pearce JH. Identification of 2 Chlamydia trachomatis antigens recognized by synovial fluid T cells from patients with Chlamydia induced reactive arthritis. J Rheumatol 1996; 23:130-6.
44. Deane KH, Jecock RM, Pearce JH, Gaston JS. Identification and characterization of a DR4-restricted T cell epitope within chlamydia heat shock protein 60. Clin Exp Immunol 1997; 109:439-45.
45. Schuppe HC, Pichlmeier U, Schenk BI, Bottcher M. Antibodies to Chlamydia trachomatis heat shock protein (cHSP60) and major outer membrane protein (MOMP) in men with impaired fertility. Clin Lab 2003; 49:273-5.
46. Clad A, Petersen EE, Dettlaff S. Antibodies to Chlamydia trachomatis heat shock protein 60 (cHSP60) and Chlamydia trachomatis major outer membrane protein (MOMP) in women with different tubal status. Clin Lab 2003; 49:269-71.
47. Kaufmann SH. Heat-shock proteins and pathogenesis of bacterial infections. Springer Semin Immunopathol 1991; 13:25-36.
48. Gervassi AL, Grabstein KH, Probst P, Hess B, Alderson MR, Fling SP. Human CD8+ T cells recognize the 60-kDa cysteine-rich outer membrane protein from Chlamydia trachomatis. J Immunol 2004; 173:6905-13.
49. Goodall JC, Beacock-Sharp H, Deane KH, Gaston JS. Recognition of the 60 kilodalton cysteine-rich outer membrane protein OMP2 by CD4+ T cells from humans infected with Chlamydia trachomatis. Clin Exp Immunol 2001; 126:488-93.
50. Wagar EA, Schachter J, Bavoil P, Stephens RS. Differential human serologic response to two 60,000 molecular weight Chlamydia trachomatis antigens. J Infect Dis 1990; 162:922-7.